mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.3 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.3 |